Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011, Article ID 587315, 11 pages
http://dx.doi.org/10.1155/2011/587315
Review Article

γδ T Cells Cross-Link Innate and Adaptive Immunity in Mycobacterium tuberculosis Infection

1Dipartimento di Biopatologia e Biotecnologie Mediche e Forensi, Università di Palermo, 90134 Palermo, Italy
2Laboratory of Cellular Immunology, National Institute for Infectious Diseases “Lazzaro Spallanzani” IRCCS, Via Portuense 292, 00149 Rome, Italy

Received 19 September 2010; Revised 27 November 2010; Accepted 9 December 2010

Academic Editor: Carl Feng

Copyright © 2011 Serena Meraviglia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. M. Vashishtha, “WHO Global Tuberculosis Control Report 2009: tuberculosis elimination is a distant dream,” Indian Pediatrics, vol. 46, no. 5, pp. 401–402, 2009. View at Google Scholar · View at Scopus
  2. A. Wright, M. Zignol, A. van Deun et al., “Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance,” Lancet, vol. 373, no. 9678, pp. 1861–1873, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. M. Small, “Tuberculosis: a new vision for the 21st century,” Kekkaku, vol. 84, no. 11, pp. 721–726, 2009. View at Google Scholar · View at Scopus
  4. I. Verma and A. Grover, “Antituberculous vaccine development: a perspective for the endemic world,” Expert Review of Vaccines, vol. 8, no. 11, pp. 1547–1553, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. Medzhitov, “Innate immunity: quo vadis?” Nature Immunology, vol. 11, no. 7, pp. 551–553, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. P. Allison and W. L. Havran, “The immunobiology of T cells with invariant γδ antigen receptors,” Annual Review of Immunology, vol. 9, pp. 679–705, 1991. View at Google Scholar · View at Scopus
  7. M. Girardi, “Immunosurveillance and immunoregulation by γδ T cells,” Journal of Investigative Dermatology, vol. 126, no. 1, pp. 25–31, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. W. Haas and S. Tonegawa, “Development and selection of γδ T cells,” Current Opinion in Immunology, vol. 4, no. 2, pp. 147–155, 1992. View at Publisher · View at Google Scholar
  9. M. Eberl and H. Jomaa, “A genetic basis for human γδ T-cell reactivity towards microbial pathogens,” Trends in Immunology, vol. 24, no. 8, pp. 407–409, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Wallace, A. M. Scharko, C. D. Pauza et al., “Functional γδ T-lymphocyte defect associated with human immunodeficiency virus infections,” Molecular Medicine, vol. 3, no. 1, pp. 60–71, 1997. View at Google Scholar · View at Scopus
  11. C. T. Morita, H. K. Lee, H. Wang, H. Li, R. A. Mariuzza, and Y. Tanaka, “Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human γδ T cells,” Journal of Immunology, vol. 167, no. 1, pp. 36–41, 2001. View at Google Scholar
  12. Y. Tanaka, “Human gamma delta T cells and tumor immunotherapy,” Journal of Clinical and Experimental Hematopathology, vol. 46, no. 1, pp. 11–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Bas, H. Bier, K. Schirlau et al., “Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck,” Oral Oncology, vol. 42, no. 7, pp. 691–697, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. P. Wrobel, H. Shojaei, B. Schittek et al., “Lysis of a broad range of epithelial tumour cells by human γδ T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition,” Scandinavian Journal of Immunology, vol. 66, no. 2-3, pp. 320–328, 2007. View at Publisher · View at Google Scholar · View at PubMed
  15. Y. Tanaka, S. Sano, E. Nieves et al., “Nonpeptide ligands for human γδ T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 17, pp. 8175–8179, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Viey, G. Fromont, B. Escudier et al., “Phosphostim-activated γδ T cells kill autologous metastatic renal cell carcinoma,” Journal of Immunology, vol. 174, no. 3, pp. 1338–1347, 2005. View at Google Scholar · View at Scopus
  17. M. Corvaisier, A. Moreau-Aubry, E. Diez et al., “Vγ9Vδ2 T cell response to colon carcinoma cells,” Journal of Immunology, vol. 175, no. 8, pp. 5481–5488, 2005. View at Google Scholar · View at Scopus
  18. E. Viey, C. Lucas, F. Romagne, B. Escudier, S. Chouaib, and A. Caignard, “Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vγ9Vδ2 T cells from renal cell carcinoma patients,” Journal of Immunotherapy, vol. 31, no. 3, pp. 313–323, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. H. J. Gober, M. Kistowska, L. Angman, P. Jenö, L. Mori, and G. de Libero, “Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells,” Journal of Experimental Medicine, vol. 197, no. 2, pp. 163–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Scotet, L. O. Martinez, E. Grant et al., “Tumor recognition following Vγ9Vδ2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I,” Immunity, vol. 22, no. 1, pp. 71–80, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. F. Poccia, B. Cipriani, S. Vendetti et al., “CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vγ9Vδ2 T lymphocytes,” Journal of Immunology, vol. 159, no. 12, pp. 6009–6017, 1997. View at Google Scholar · View at Scopus
  22. V. Kunzmann, E. Kretzschmar, T. Herrmann, and M. Wilhelm, “Polyinosinic-polycytidylic acid-mediated stimulation of human γδ T cells via CD11c dendritic cell-derived type I interferons,” Immunology, vol. 112, no. 3, pp. 369–377, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. K. Pietschmann, S. Beetz, S. Welte et al., “Toll-like receptor expression and function in subsets of human γδ T lymphocytes,” Scandinavian Journal of Immunology, vol. 70, no. 3, pp. 245–255, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. D. Wesch, S. Beetz, H. H. Oberg, M. Marget, K. Krengel, and D. Kabelitz, “Direct costimulatory effect of TLR3 ligand poly(I:C) on human γδ lymphocytes,” Journal of Immunology, vol. 176, no. 3, pp. 1348–1354, 2006. View at Google Scholar · View at Scopus
  25. Y. Shen, D. Zhou, L. Qiu et al., “Adaptive immune response of Vγ2Vδ2 T cells during mycobacterial infections,” Science, vol. 295, no. 5563, pp. 2255–2258, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. F. Dieli, F. Poccia, M. Lipp et al., “Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites,” Journal of Experimental Medicine, vol. 198, no. 3, pp. 391–397, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. J. Morrison, M. Pai, and P. C. Hopewell, “Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis,” Lancet Infectious Diseases, vol. 8, no. 6, pp. 359–368, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. D. S. Korbel, B. E. Schneider, and U. E. Schaible, “Innate immunity in tuberculosis: myths and truth,” Microbes and Infection, vol. 10, no. 9, pp. 995–1004, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. Y. Poquet, F. Halary, E. Champagne et al., “Human γδ T cells in tuberculosis,” Research in Immunology, vol. 147, no. 8-9, pp. 542–549, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Szereday, Z. Baliko, and J. Szekeres-Bartho, “The role of Vδ2+T-cells in patients with active Mycobacterium tuberculosis infection and tuberculin anergy,” International Journal of Tuberculosis and Lung Disease, vol. 12, no. 3, pp. 262–268, 2008. View at Google Scholar · View at Scopus
  31. E. M. Janis, S. H. E. Kaufmann, R. H. Schwartz, and D. M. Pardoll, “Activation of γδ T cells in the primary immune response to Mycobacterium tuberculosis,” Science, vol. 244, no. 4905, pp. 713–716, 1989. View at Google Scholar · View at Scopus
  32. P. De Paoli, D. Gennari, P. Martelli, G. Basaglia, M. Crovatto, and S. Battistin, “A subset of γδ lymphocytes is increased during HIV-1 infection,” Clinical and Experimental Immunology, vol. 83, no. 2, pp. 187–191, 1991. View at Google Scholar · View at Scopus
  33. F. Martini, R. Urso, C. Gioia et al., “γδ T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy,” Immunology, vol. 100, no. 4, pp. 481–486, 2000. View at Publisher · View at Google Scholar
  34. J. Holoshitz, F. Koning, J. E. Coligan, J. de Bruyn, and S. Strober, “Isolation of CD4 CD8 mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid,” Nature, vol. 339, no. 6221, pp. 226–231, 1989. View at Google Scholar · View at Scopus
  35. R. L. Modlin, C. Pirmez, F. M. Hofman et al., “Lymphocytes bearing antigen-specific γδ T-cell receptors accumulate in human infectious disease lesions,” Nature, vol. 339, no. 6225, pp. 544–548, 1989. View at Google Scholar · View at Scopus
  36. D. Kabelitz, A. Bender, T. Prospero, S. Wesselborg, O. Janssen, and K. Pechhold, “The primary response of human γ/δ T cells to Mycobacterium tuberculosis is restricted to Vγ9-bearing cells,” Journal of Experimental Medicine, vol. 173, no. 6, pp. 1331–1338, 1991. View at Google Scholar · View at Scopus
  37. G. de Libero, G. Casorati, C. Giachino et al., “Selection by two powerful antigens may account for the presence of the major population of human peripheral γ/δ T cells,” Journal of Experimental Medicine, vol. 173, no. 6, pp. 1311–1322, 1991. View at Google Scholar · View at Scopus
  38. W. H. Boom, K. A. Chervenak, M. A. Mincek, and J. J. Ellner, “Role of the mononuclear phagocyte as an antigen-presenting cell for human γδ T cells activated by live Mycobacterium tuberculosis,” Infection and Immunity, vol. 60, no. 9, pp. 3480–3488, 1992. View at Google Scholar · View at Scopus
  39. D. V. Havlir, J. J. Ellner, K. A. Chervenak, and W. H. Boom, “Selective expansion of human γδ T cells by monocytes infected with live Mycobacterium tuberculosis,” Journal of Clinical Investigation, vol. 87, no. 2, pp. 729–733, 1991. View at Google Scholar · View at Scopus
  40. W. Haas, P. Pereira, and S. Tonegawa, “Gamma/delta cells,” Annual Review of Immunology, vol. 11, pp. 637–685, 1993. View at Google Scholar
  41. M. E. Munk, A. J. Gatrill, and S. H. E. Kaufmann, “Target cell lysis and IL-2 secretion by γ/δ T lymphocytes after activation with bacteria,” Journal of Immunology, vol. 145, no. 8, pp. 2434–2439, 1990. View at Google Scholar · View at Scopus
  42. R. Casetti and A. Martino, “The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy,” Cellular & Molecular Immunology, vol. 5, no. 3, pp. 161–170, 2008. View at Google Scholar · View at Scopus
  43. C. Gioia, C. Agrati, D. Goletti et al., “Different cytokine production and effector/memory dynamics of αβ+ or γδ+ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis,” International Journal of Immunopathology and Pharmacology, vol. 16, no. 3, pp. 247–252, 2003. View at Google Scholar
  44. R. Casetti, G. Perretta, A. Taglioni et al., “Drug-induced expansion and differentiation of Vγ9Vδ2 T cells in vivo: the role of exogenous IL-2,” Journal of Immunology, vol. 175, no. 3, pp. 1593–1598, 2005. View at Google Scholar · View at Scopus
  45. F. Dieli, M. Troye-Blomberg, J. Ivanyi et al., “Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by V-γ9/Vδ2 T lymphocytes,” Journal of Infectious Diseases, vol. 184, no. 8, pp. 1082–1085, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. X. Lai, Y. Shen, D. Zhou et al., “Immune biology of macaque lymphocyte populations during mycobacterial infection,” Clinical and Experimental Immunology, vol. 133, no. 2, pp. 182–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. J. A. M. Langermans, P. Andersen, D. van Soolingen et al., “Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11497–11502, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. F. Dieli, J. Ivanyi, P. Marsh et al., “Characterization of lung γδ T cells following intranasal infection with Mycobacterium bovis bacillus Calmette-Guérin,” Journal of Immunology, vol. 170, no. 1, pp. 463–469, 2003. View at Google Scholar · View at Scopus
  49. J. Ismaili, V. Olislagers, R. Poupot, J. J. Fournié, and M. Goldman, “Human γδ T cells induce dendritic cell maturation,” Clinical Immunology, vol. 103, no. 3, pp. 296–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Conti, R. Casetti, M. Cardone et al., “Reciprocal activating interaction between dendritic cells and pamidronate-stimulated γδ T cells: role of CD86 and inflammatory cytokines,” Journal of Immunology, vol. 174, no. 1, pp. 252–260, 2005. View at Google Scholar · View at Scopus
  51. A. Martino, R. Casetti, A. D'Alessandri, A. Sacchi, and F. Poccia, “Complementary function of γδ T-lymphocytes and dendritic cells in the response to isopentenyl-pyrophosphate and lipopolysaccharide antigens,” Journal of Clinical Immunology, vol. 25, no. 3, pp. 230–237, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. D. Förtsch, M. Röllinghoff, and S. Stenger, “IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis,” Journal of Immunology, vol. 165, no. 2, pp. 978–987, 2000. View at Google Scholar · View at Scopus
  53. R. E. Tascon, C. S. Soares, S. Ragno, E. Stavropoulos, E. M. A. Hirst, and M. J. Colston, “Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice,” Immunology, vol. 99, no. 3, pp. 473–480, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Demangel and W. J. Britton, “Interaction of dendritic cells with mycobacteria: where the action starts,” Immunology and Cell Biology, vol. 78, no. 4, pp. 318–324, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. L. Tailleux, O. Neyrolles, S. Honoré-Bouakline et al., “Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells,” Journal of Immunology, vol. 170, no. 4, pp. 1939–1948, 2003. View at Google Scholar · View at Scopus
  56. L. Tallieux, O. Schwartz, J. L. Herrmann et al., “DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells,” Journal of Experimental Medicine, vol. 197, no. 1, pp. 121–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Banchereau and R. M. Steinman, “Dendritic cells and the control of immunity,” Nature, vol. 392, no. 6673, pp. 245–252, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. M. Buettner, C. Meinken, M. Bastian et al., “Inverse correlation of maturity and antibacterial activity in human dendritic cells,” Journal of Immunology, vol. 174, no. 7, pp. 4203–4209, 2005. View at Google Scholar · View at Scopus
  59. N. Dulphy, J. L. Herrmann, J. Nigou et al., “Intermediate maturation of Mycobacterium tuberculosis LAM-activated human dendritic cells,” Cellular Microbiology, vol. 9, no. 6, pp. 1412–1425, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. A. J. Wolf, B. Linas, G. J. Trevejo-Nuñez et al., “Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo,” Journal of Immunology, vol. 179, no. 4, pp. 2509–2519, 2007. View at Google Scholar · View at Scopus
  61. S. Meraviglia, N. Caccamo, A. Salerno, G. Sireci, and F. Dieli, “Partial and ineffective activation of Vγ9Vδ2 T cells by Mycobacterium tuberculosis-infected dendritic cells,” Journal of Immunology, vol. 185, no. 3, pp. 1770–1776, 2010. View at Publisher · View at Google Scholar · View at PubMed
  62. A. Martino, R. Casetti, A. Sacchi, and F. Poccia, “Central memory Vγ9Vδ2 T lymphocytes primed and expanded by bacillus Calmette-Guérin-infected dendritic cells kill mycobacterial-infected monocytes,” Journal of Immunology, vol. 179, no. 5, pp. 3057–3064, 2007. View at Google Scholar · View at Scopus
  63. N. Caccamo, S. Meraviglia, V. Ferlazzo et al., “Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vγ9Vδ2 naive, memory and effector T cell subsets,” European Journal of Immunology, vol. 35, no. 6, pp. 1764–1772, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. P. F. Barnes, C. L. Grisso, J. S. Abrams, H. Band, T. H. Rea, and R. L. Modlin, “γδ T lymphocytes in human tuberculosis,” Journal of Infectious Diseases, vol. 165, no. 3, pp. 506–512, 1992. View at Google Scholar · View at Scopus
  65. C. Ueta, I. Tsuyuguchi, H. Kawasumi, T. Takashima, H. Toba, and S. Kishimoto, “Increase of γ/δ T cells in hospital workers who are in close contact with tuberculosis patients,” Infection and Immunity, vol. 62, no. 12, pp. 5434–5441, 1994. View at Google Scholar · View at Scopus
  66. M. Ito, N. Kojiro, T. Ikeda, T. Ito, J. Funada, and T. Kokubu, “Increased proportions of peripheral blood γδ T cells in patients with pulmonary tuberculosis,” Chest, vol. 102, no. 1, pp. 195–197, 1992. View at Google Scholar · View at Scopus
  67. S. K. Schwander, E. Sada, M. Torres et al., “T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis,” Journal of Infectious Diseases, vol. 173, no. 5, pp. 1267–1272, 1996. View at Google Scholar · View at Scopus
  68. T. N. Mazzola, M. T. N. da Silva, Y. M. F. Moreno et al., “Robust γδ T cell expansion in infants immunized at birth with BCG vaccine,” Vaccine, vol. 25, no. 34, pp. 6313–6320, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. F. Dieli, G. Sireci, N. Caccamo et al., “Selective depression of interferon-γ and granulysin production with increase of proliferative response by Vγ9/Vδ2 T cells in children with tuberculosis,” Journal of Infectious Diseases, vol. 186, no. 12, pp. 1835–1839, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. A. Tazi, I. Fajac, P. Soler, D. Valeyre, J. P. Battesti, and A. J. Hance, “Gamma/delta T-lymphocytes are not increased in number in granulomatous lesions of patients with tuberculosis or sarcoidosis,” American Review of Respiratory Disease, vol. 144, no. 6, pp. 1373–1375, 1991. View at Google Scholar · View at Scopus
  71. F. Dieli, G. Friscia, C. Di Sano et al., “Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy,” Journal of Infectious Diseases, vol. 180, no. 1, pp. 225–228, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. F. O. Sanchez, J. I. Rodriguez, G. Agudelo, and L. F. Garcia, “Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls,” Infection and Immunity, vol. 62, no. 12, pp. 5673–5678, 1994. View at Google Scholar · View at Scopus
  73. A. A. Manfredi, S. Heltai, P. Rovere et al., “Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of γδ T cells to cause apoptosis,” European Journal of Immunology, vol. 28, no. 6, pp. 1798–1806, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. C. T. Weaver, L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy, “Th17: an effector CD4 T cell lineage with regulatory T cell ties,” Immunity, vol. 24, no. 6, pp. 677–688, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. B. Kanwar, D. Favre, and J. M. McCune, “Th17 and regulatory T cells: implications for AIDS pathogenesis,” Current Opinion in HIV and AIDS, vol. 5, no. 2, pp. 151–157, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. K. Narita, D.-L. Hu, F. Mori, K. Wakabayashi, Y. Iwakura, and A. Nakane, “Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A,” Infection and Immunity, vol. 78, no. 10, pp. 4234–4242, 2010. View at Publisher · View at Google Scholar · View at PubMed
  77. F. L. van de Veerdonk, A. C. Teirlinck, J. Kleinnijenhuis et al., “Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1,” Journal of Leukocyte Biology, vol. 88, no. 2, pp. 227–232, 2010. View at Publisher · View at Google Scholar · View at PubMed
  78. M. Umemura, A. Yahagi, S. Hamada et al., “IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guérin infection,” Journal of Immunology, vol. 178, no. 6, pp. 3786–3796, 2007. View at Google Scholar · View at Scopus
  79. M. Y. Peng, Z. H. Wang, C. Y. Yao et al., “Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis,” Cellular & Molecular Immunology, vol. 5, no. 3, pp. 203–208, 2008. View at Google Scholar · View at Scopus
  80. E. Lockhart, A. M. Green, and J. L. Flynn, “IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection,” Journal of Immunology, vol. 177, no. 7, pp. 4662–4669, 2006. View at Google Scholar · View at Scopus
  81. S. Yao, D. Huang, C. Y. Chen et al., “Differentiation, distribution and γδ T cell-driven regulation of IL-22-producing T cells in tuberculosis,” PLoS Pathogens, vol. 6, no. 2, Article ID e1000789, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. D. Kabelitz, D. Wesch, E. Pitters, and M. Zöller, “Characterization of tumor reactivity of human Vγ9Vδ2 γδ T cells in vitro and in SCID mice in vivo,” Journal of Immunology, vol. 173, no. 11, pp. 6767–6776, 2004. View at Google Scholar · View at Scopus
  83. M. Wilhelm, V. Kunzmann, S. Eckstein et al., “γδ T cells for immune therapy of patients with lymphoid malignancies,” Blood, vol. 102, no. 1, pp. 200–206, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. F. Dieli, D. Vermijlen, F. Fulfaro et al., “Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer,” Cancer Research, vol. 67, no. 15, pp. 7450–7457, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. S. H. E. Kaufmann, “Immune response to tuberculosis: experimental animal models,” Tuberculosis, vol. 83, no. 1–3, pp. 107–111, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. A. W. Skeiky and J. C. Sadoff, “Advances in tuberculosis vaccine strategies,” Nature Reviews Microbiology, vol. 4, no. 6, pp. 469–476, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. H. Sicard, S. Ingoure, B. Luciani et al., “In vivo immunomanipulation of Vγ9Vδ2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model,” Journal of Immunology, vol. 175, no. 8, pp. 5471–5480, 2005. View at Google Scholar · View at Scopus
  88. D. Cendron, S. Ingoure, A. Martino et al., “A tuberculosis vaccine base on phosphoantigens and fusion proteins induces distinct γδ and αβ T cell responses in primates,” European Journal of Immunology, vol. 37, no. 2, pp. 549–565, 2007. View at Publisher · View at Google Scholar · View at PubMed
  89. Y. H. Gan, M. Wallace, and M. Malkovsky, “Fas-dependent, activation-induced cell death of γδ cells,” Journal of Biological Regulators and Homeostatic Agents, vol. 15, no. 3, pp. 277–285, 2001. View at Google Scholar · View at Scopus